|
Volumn 67, Issue 11, 2010, Pages 929-931
|
Implementation of a $4 generic drug program in a 340B pharmacy
|
Author keywords
Drugs; Economics; Formularies; Health benefit programs; Pharmacy; Prescriptions; Pricing; Sociology; United States
|
Indexed keywords
AMITRIPTYLINE;
ATENOLOL;
GENERIC DRUG;
HYDROCHLOROTHIAZIDE;
LISINOPRIL;
METFORMIN;
METOPROLOL TARTRATE;
NAPROXEN;
RANITIDINE;
TRAZODONE;
WARFARIN;
PRESCRIPTION DRUG;
ARTICLE;
DRUG COST;
HEALTH CARE PLANNING;
HEALTH CENTER;
HEALTH PROGRAM;
HUMAN;
INCOME;
MEDICAID;
PHARMACY;
POVERTY;
PRESCRIPTION;
PRIORITY JOURNAL;
UNITED STATES;
ECONOMICS;
HEALTH CARE DELIVERY;
LEGAL ASPECT;
ORGANIZATION AND MANAGEMENT;
COMMUNITY HEALTH CENTERS;
DRUG COSTS;
DRUGS, GENERIC;
HEALTH SERVICES ACCESSIBILITY;
HUMANS;
PHARMACEUTICAL SERVICES;
POVERTY;
PRESCRIPTION DRUGS;
UNITED STATES;
|
EID: 77955894100
PISSN: 10792082
EISSN: 15352900
Source Type: Journal
DOI: 10.2146/ajhp090269 Document Type: Article |
Times cited : (5)
|
References (6)
|